All News Archive — Page 122 of 154
-
June 27, 2023
Rare disorder sheds light on dysbindin function
A case study of a rare disorder uncovers roles for the protein dysbindin in the adaptive immune response and suggests that mutations may underlie some cases of very early onset inflammatory bowel disease. -
June 26, 2023
Magnesium deficiency and blood pressure
Dietary magnesium depletion in a mouse model activated inflammatory pathways and molecules that promote hypertension, suggesting that increased magnesium consumption may be beneficial for reducing the prevalence of hypertension. -
June 26, 2023
David Haynes Named VUMC’s Chief Patient Experience Officer
-
June 22, 2023
Pathways to a healthy liver
Hepatic stellate cells maintain liver mass and function; the signaling factors they use could be exploited therapeutically to promote liver regeneration and inhibit cancerous proliferation, Vanderbilt researchers suggest. -
June 22, 2023
Mosaicism and genetic disease
Genetic mosaicism — when the body’s cells do not all have the same genetic makeup — could generate variants previously thought to be spontaneous in genetic disease, and detecting parental mosaicism could clarify recurrence risk for future children. -
June 22, 2023
Neurocritical care team helps boy survive severe brain injury
Vanderbilt's pediatric neurocritical care team combines experts from different areas of pediatric medicine to care for each child according to individual needs to maximize that child’s quality recovery. -
June 22, 2023
VUMC, Oxford team develops ‘blueprint’ to block lethal virus
Researchers at Vanderbilt University Medical Center and the University of Oxford have determined how a human monoclonal antibody isolated at Vanderbilt in 2021 can prevent infection by the potentially lethal Sin Nombre virus.